Covered recipient · General Payments record
RACHEL R WILCINOT
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,580.60
- Reported across 172 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $492.16 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $167.67 | 11 |
| PFIZER INC. | $134.05 | 11 |
| Mylan Specialty L.P. | $52.52 | 3 |
| Novo Nordisk AS | $43.90 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $35.14 | 2 |
| Acerta Pharma LLC | $16.10 | 1 |
| E.R. Squibb & Sons, L.L.C. | $15.88 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $13.52 | 1 |
| Lilly USA, LLC | $13.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $22.69 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116208527 | CMS |
| Amgen Inc. | $11.44 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116208532 | CMS |
| Amgen Inc. | $12.67 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117717912 | CMS |
| Amgen Inc. | $17.04 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116208535 | CMS |
| Amgen Inc. | $18.40 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117717914 | CMS |
| Amgen Inc. | $21.31 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116208540 | CMS |
| Amgen Inc. | $11.60 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117717916 | CMS |
| Amgen Inc. | $15.89 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116208548 | CMS |
| Amgen Inc. | $20.43 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116208544 | CMS |
| Amgen Inc. | $8.32 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117717918 | CMS |
| Amgen Inc. | $7.88 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117717920 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.10 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105495041 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.22 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118223299 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.92 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118223295 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.88 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101350822 | CMS |
| Lilly USA, LLC | $13.38 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135300655 | CMS |
| Mylan Specialty L.P. | $16.39 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147352169 | CMS |
| Mylan Specialty L.P. | $16.98 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147287236 | CMS |
| Mylan Specialty L.P. | $19.15 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147341497 | CMS |
| Novartis Pharmaceuticals Corporation | $13.52 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087405658 | CMS |
| Novo Nordisk Inc | $18.90 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096892503 | CMS |
| Novo Nordisk Inc | $25.00 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097770518 | CMS |
| PFIZER INC. | $8.93 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131235012 | CMS |
| PFIZER INC. | $8.68 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130900816 | CMS |
| PFIZER INC. | $10.27 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130900059 | CMS |
| PFIZER INC. | $5.27 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130901515 | CMS |
| PFIZER INC. | $8.16 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130920316 | CMS |
| PFIZER INC. | $8.22 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130932721 | CMS |
| PFIZER INC. | $38.09 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131812992 | CMS |
| PFIZER INC. | $15.62 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131835582 | CMS |
| PFIZER INC. | $5.83 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130961682 | CMS |
| PFIZER INC. | $14.21 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131180611 | CMS |
| PFIZER INC. | $10.77 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131154552 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.